Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873989 · ClinicalTrials.gov registry record · Phase 1
Testosterone Replacement for Male Opioid Agonist Maintained Patients
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01873989 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 15 participants.
The verdict
NCT01873989, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
Interventions
- OTHER Waitlist control
- DRUG Testosterone replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01873989
The ClinicalTrials.gov registry entry for NCT01873989 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist control is the first listed.
NCT01873989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01873989 about?
NCT01873989 is a clinical study titled "Testosterone Replacement for Male Opioid Agonist Maintained Patients". This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
What is the current status of trial NCT01873989?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01873989?
The interventions under investigation include: Waitlist control (OTHER), Testosterone replacement (DRUG).
Who is sponsoring clinical trial NCT01873989?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.